You are here

Drugmaker Mylan's woes get worse with president engulfed in vast probe

He is one of those accused of colluding in conspiracy to prop up prices

San Francisco

MYLAN NV's latest troubles couldn't come at a worse time.

Two years ago, Mylan was a swaggering drugmaker on the way up, buying up rivals as it grew and diversified.

Then it faced political scrutiny over price hikes for its EpiPen allergy shot and increasing

sentifi.com

Market voices on:

Powered by GET.comGetCom